<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>CytoCares | wechat-feeds</title><link>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</link><description>为您传递细胞治疗相关行业信息与技术进展，共同促进国内免疫治疗技术发展与行业繁荣。</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 16 Jun 2021 19:16:24 +0800</pubDate><image><url>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</url><title>CytoCares | wechat-feeds</title><link>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>再生元｜PD-1+CD28 X TSA 双抗，能持久抗瘤么？</title><link>https://mp.weixin.qq.com/s/-7QAWLWEBYhYDAvRZtmGIg</link><description></description><content:encoded><![CDATA[再生元｜PD-1+CD28 X TSA 双抗，能持久抗瘤么？]]></content:encoded><pubDate>Wed, 16 Jun 2021 18:25:34 +0800</pubDate></item><item><title>Nature重磅：全球癌症细胞治疗研发管线汇总，增长迅速、中美领跑</title><link>https://mp.weixin.qq.com/s/8eZemrenmYtxCk2qJduksw</link><description></description><content:encoded><![CDATA[Nature重磅：全球癌症细胞治疗研发管线汇总，增长迅速、中美领跑]]></content:encoded><pubDate>Tue, 15 Jun 2021 18:40:06 +0800</pubDate></item><item><title>抗体药物动态-20210615</title><link>https://mp.weixin.qq.com/s/YkBv8JXLgoFLUX4ua0MKuQ</link><description></description><content:encoded><![CDATA[抗体药物动态-20210615]]></content:encoded><pubDate>Tue, 15 Jun 2021 18:40:06 +0800</pubDate></item><item><title>调节性B细胞：表型、功能、疾病</title><link>https://mp.weixin.qq.com/s/Cse8LVX08q5NC_Y2aVkwGQ</link><description></description><content:encoded><![CDATA[调节性B细胞：表型、功能、疾病]]></content:encoded><pubDate>Thu, 10 Jun 2021 17:54:21 +0800</pubDate></item><item><title>肿瘤免疫明星靶点之CD137：双抗及Combo策略</title><link>https://mp.weixin.qq.com/s/Spa68HWQj4xAKdur4HhSDw</link><description></description><content:encoded><![CDATA[肿瘤免疫明星靶点之CD137：双抗及Combo策略]]></content:encoded><pubDate>Wed, 09 Jun 2021 18:48:32 +0800</pubDate></item><item><title>抗体药物动态-20210609</title><link>https://mp.weixin.qq.com/s/ilR5bpJOUXSKNdBNhMPi5A</link><description></description><content:encoded><![CDATA[抗体药物动态-20210609]]></content:encoded><pubDate>Wed, 09 Jun 2021 18:48:32 +0800</pubDate></item><item><title>渤健新药满城风雨，靶向TREM2会是AD新希望么？</title><link>https://mp.weixin.qq.com/s/hccMQLerUYW4RAe9moWnoQ</link><description></description><content:encoded><![CDATA[渤健新药满城风雨，靶向TREM2会是AD新希望么？]]></content:encoded><pubDate>Tue, 08 Jun 2021 18:39:52 +0800</pubDate></item><item><title>CAR-T治疗癌症的最新综述</title><link>https://mp.weixin.qq.com/s/euMI49D5L-yN7JvXydvK6Q</link><description></description><content:encoded><![CDATA[CAR-T治疗癌症的最新综述]]></content:encoded><pubDate>Mon, 07 Jun 2021 19:54:58 +0800</pubDate></item><item><title>抗体药物动态-20210607</title><link>https://mp.weixin.qq.com/s/hR187GWLRf192YClCGb6Ug</link><description></description><content:encoded><![CDATA[抗体药物动态-20210607]]></content:encoded><pubDate>Mon, 07 Jun 2021 19:54:58 +0800</pubDate></item><item><title>DMF备案全能核酸酶，为生物制品解决核酸残留困扰</title><link>https://mp.weixin.qq.com/s/9LHPPv5-ioYQQUjH_RIQwg</link><description></description><content:encoded><![CDATA[DMF备案全能核酸酶，为生物制品解决核酸残留困扰]]></content:encoded><pubDate>Fri, 04 Jun 2021 19:51:03 +0800</pubDate></item><item><title>VEGFR-2单抗的进阶多面杀癌之路</title><link>https://mp.weixin.qq.com/s/77pOjJ_XbUR6HlLyWYJMYw</link><description></description><content:encoded><![CDATA[VEGFR-2单抗的进阶多面杀癌之路]]></content:encoded><pubDate>Fri, 04 Jun 2021 19:51:03 +0800</pubDate></item><item><title>四种靶向肿瘤相关巨噬细胞的策略</title><link>https://mp.weixin.qq.com/s/ZmpdW9Enbxlz_8NRiLMleQ</link><description></description><content:encoded><![CDATA[四种靶向肿瘤相关巨噬细胞的策略]]></content:encoded><pubDate>Thu, 03 Jun 2021 19:08:44 +0800</pubDate></item><item><title>抗体药物动态-20210603</title><link>https://mp.weixin.qq.com/s/2mAjdfeikyCcRyJQb8wZ0g</link><description></description><content:encoded><![CDATA[抗体药物动态-20210603]]></content:encoded><pubDate>Thu, 03 Jun 2021 19:08:44 +0800</pubDate></item><item><title>CAR-T治疗中的细胞因子释放综合征与相关神经毒性</title><link>https://mp.weixin.qq.com/s/urDOaWCN5X-fuZEF4AOvtw</link><description></description><content:encoded><![CDATA[CAR-T治疗中的细胞因子释放综合征与相关神经毒性]]></content:encoded><pubDate>Wed, 02 Jun 2021 19:11:31 +0800</pubDate></item><item><title>抗体药物动态-20210602</title><link>https://mp.weixin.qq.com/s/1UHhbOmo0ddkgumsoAxumQ</link><description></description><content:encoded><![CDATA[抗体药物动态-20210602]]></content:encoded><pubDate>Wed, 02 Jun 2021 19:11:31 +0800</pubDate></item><item><title>IL7融合蛋白临床疗效初现</title><link>https://mp.weixin.qq.com/s/QRXj5WvG1JsMz6oi90UycQ</link><description></description><content:encoded><![CDATA[IL7融合蛋白临床疗效初现]]></content:encoded><pubDate>Tue, 01 Jun 2021 18:36:09 +0800</pubDate></item></channel></rss>